참고문헌
- Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21:538-582. https://doi.org/10.1128/CMR.00058-07
- Chung DR, Song JH, Kim SH, et al. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med 2011;184:1409-1417. https://doi.org/10.1164/rccm.201102-0349OC
- Talbot GH, Bradley J, Edwards JE Jr, et al. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006;42:657-668. https://doi.org/10.1086/499819
- Lee HW, Koh YM, Kim J, et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect 2008;14:49-54. https://doi.org/10.1111/j.1469-0691.2007.01842.x
- Espinal P, Marti S, Vila J. Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J Hosp Infect 2012;80:56-60. https://doi.org/10.1016/j.jhin.2011.08.013
- Da Silva G, Dijkshoorn L, van der Reijden T, van Strijen B, Duarte A. Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone II. Clin Microbiol Infect 2007;13:190-195. https://doi.org/10.1111/j.1469-0691.2006.01628.x
- Kaliterna V, Goic-Barisic I. The ability of biofilm formation in clinical isolates of Acinetobacter baumannii belonging to two different European clones causing outbreaks in the Split University Hospital, Croatia. J Chemother 2013;25:60-62. https://doi.org/10.1179/1973947812Y.0000000052
- Arvaniti K, Lathyris D, Ruimy R, et al. The importance of colonization pressure in multiresistant Acinetobacter baumannii acquisition in a Greek intensive care unit. Crit Care 2012;16:R102. https://doi.org/10.1186/cc11383
- Sheng WH, Liao CH, Lauderdale TL, et al. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int J Infect Dis 2010;14:e764-e769. https://doi.org/10.1016/j.ijid.2010.02.2254
- Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-332. https://doi.org/10.1016/j.ajic.2008.03.002
- Pettit RK, Weber CA, Kean MJ, et al. Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Chemother 2005;49:2612-2617. https://doi.org/10.1128/AAC.49.7.2612-2617.2005
- Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology 2003;149(Pt 12):3473-3484. https://doi.org/10.1099/mic.0.26541-0
- Kim HA, Ryu SY, Seo I, Suh SI, Suh MH, Baek WK. Biofilm formation and colistin susceptibility of Acinetobacter baumannii isolated from Korean nosocomial samples. Microb Drug Resist 2015;21:452-457. https://doi.org/10.1089/mdr.2014.0236
- Lim CJ, Cheng AC, Kennon J, et al. Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: a nested case-control study. J Antimicrob Chemother 2014;69:1972-1980. https://doi.org/10.1093/jac/dku077
- Pneumatikos IA, Dragoumanis CK, Bouros DE. Ventilator-associated pneumonia or endotracheal tube-associated pneumonia? An approach to the pathogenesis and preventive strategies emphasizing the importance of endotracheal tube. Anesthesiology 2009;110:673-680. https://doi.org/10.1097/ALN.0b013e31819868e0
- Gil-Perotin S, Ramirez P, Marti V, et al. Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept. Crit Care 2012;16:R93. https://doi.org/10.1186/cc11357
- Zago CE, Silva S, Sanita PV, et al. Dynamics of biofilm formation and the interaction between Candida albicans and methicillin-susceptible (MSSA) and -resistant Staphylococcus aureus (MRSA). PLoS One 2015;10:e0123206. https://doi.org/10.1371/journal.pone.0123206
- Gaddy JA, Tomaras AP, Actis LA. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect Immun 2009;77:3150-3160. https://doi.org/10.1128/IAI.00096-09
피인용 문헌
- In vitro effect of subminimal inhibitory concentrations of antibiotics on the biofilm formation ability of Acinetobacter baumannii clinical isolates vol.30, pp.1, 2017, https://doi.org/10.1080/1120009x.2017.1378835
- Biofilm Formation and Detection of Fluoroquinolone- and Carbapenem-Resistant Genes in Multidrug-Resistant Acinetobacter baumannii vol.2019, pp.None, 2017, https://doi.org/10.1155/2019/3454907
- A Study on Acinetobacter baumannii and Staphylococcus aureus Strains Recovered from the Same Infection Site of a Diabetic Patient vol.76, pp.7, 2019, https://doi.org/10.1007/s00284-019-01696-7
- Role of PstS in the Pathogenesis of Acinetobacter baumannii Under Microaerobiosis and Normoxia vol.222, pp.7, 2017, https://doi.org/10.1093/infdis/jiaa201
- Analysis of the Phospholipid Profile of the Collection Strain PAO1 and Clinical Isolates of Pseudomonas aeruginosa in Relation to Their Attachment Capacity vol.22, pp.8, 2017, https://doi.org/10.3390/ijms22084003
- Gram-Negative Bacteria Holding Together in a Biofilm: The Acinetobacter baumannii Way vol.9, pp.7, 2021, https://doi.org/10.3390/microorganisms9071353
- Relationship between the Biofilm-Forming Capacity and Antimicrobial Resistance in Clinical Acinetobacter baumannii Isolates: Results from a Laboratory-Based In Vitro Study vol.9, pp.11, 2017, https://doi.org/10.3390/microorganisms9112384